Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
190.00
Ask:
198.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Directorate Change

20 Apr 2026 07:00

RNS Number : 0182B
Norman Broadbent PLC
20 April 2026
 

Norman Broadbent plc

("Norman Broadbent", or the "Company")

 

Directorate Change

Norman Broadbent (LSE AIM: NBB), a leading Executive Search and Interim Management firm, announces the

appointment of Dr. Annette Nabavi to the Board as an independent non-executive director with effect from 1 May 2026 with Annette assuming the roles of Chair of the Remuneration Committee and member of the Audit Committee upon appointment. 

 

Annette brings over 30 years of experience in operational and advisory roles including driving growth through team building and international diversification, and through acquisition and partnerships. Annette currently sits on the boards of Eleco plc and Iomart Group plc, two AIM companies. At Eleco, Annette is Senior Independent Director, Chair of the Remuneration Committee and is a member of the Audit & Risk, the Nominations and the Environmental, Social & Governance Committees. At Iomart, Annette is Chair of the Remuneration Committee and is a member of the Audit and the Nominations Committees. She has held several other non-executive director roles, including at Maintel Holdings Plc, where she also chaired the Remuneration Committee. Her remuneration experience is also reflected in her involvement with the Quoted Companies Alliance (QCA), where she supported the update to the Remuneration Committee Guide published in 2021. Annette is Finance Director for Women in Telecoms and Technology, a Not-for-Profit organisation.

 

Peter Searle, Chairman of Norman, Broadbent said: "Annette is an accomplished business leader who brings highly relevant and valuable expertise to the Norman Broadbent Board. Her broad operational and advisory background is complemented by her specialist remuneration skillset and extensive experience as a NED. We are delighted to welcome Annette to the Board. To attract someone with her pedigree speaks volumes for the significant opportunity we have ahead."

 

Annette Nabavi, commented: "I am delighted to be joining Norman Broadbent at this exciting stage in its journey as a listed business. Norman Broadbent has not only weathered the storm of a difficult market environment over the last few years, but under its proven leadership team, the business has been transformed as a market leading executive search firm with broader capabilities. The business is in good shape financially and, with a clear strategy based on disciplined organic investment and M&A, I look forward to supporting the team to drive the next stage of growth."

 

The Board is looking to appoint a further independent non-executive director in due course. Further announcements will be made as appropriate. 

 

Appendix

 

Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Annette Nabavi: 

 

The following additional information is provided with regards to the appointment of Annette Patricia Nabavi (née Lane), aged 74, in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

 

Current Directorships

Previous Directorships held in the past five years

Eleco plc

Iomart Group plc

Women in Telecoms and Technology (WITT) Ltd

 

EFI Group Ltd

Maintel Group plc

Anchusa Consulting Ltd

Talan UK & Ireland Limited

 

 

Dr. Nabavi does not hold any shares, options or warrants in the Company as at the date of this announcement.

 

There is no further information regarding Dr. Nabavi required to be disclosed under the AIM Rules.

 

For further information please contact:

 

Norman Broadbent plc 

+44 (0)20 7484 0000

Kevin Davidson, CEO 

Mehr Malik, CFO

 

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Nominated Adviser and Sole Broker

Julian Blunt, Seamus Fricker, Andrea Callaghan - Corporate Finance

Jasper Berry, Matt Lewis - Sales / Corporate Broking

Gracechurch Group

+44 (0)20 4582 3500

Financial Media & Investor Relations

normanbroadbent@gracechurchpr.com

Murdo Montgomery

Tommy Bryson

Anysia Virdi

  

About Norman Broadbent:

 

Norman Broadbent (AIM: NBB) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally.

 ​ 

Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.

 

www.normanbroadbent.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUGUCUPQGPB
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.